Suppr超能文献

儿童错配修复缺陷(CMMRD)用阿司匹林预防癌症。

Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).

机构信息

Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

Eur J Hum Genet. 2018 Oct;26(10):1417-1423. doi: 10.1038/s41431-018-0197-0. Epub 2018 Jun 14.

Abstract

Constitutional MisMatch Repair Deficiency (CMMRD) is caused by homozygous or compound heterozygous germline variants in one of the mismatch repair (MMR) genes (MSH2, MSH6, PMS2, MLH1). This syndrome results in early onset colorectal cancer, leukemia and lymphoma, brain tumors and other malignancies. Children with CMMRD are at high risk of developing multiple cancers and cancer surveillance does not guarantee detection of cancer at a curable stage. The development of a preventive treatment strategy would be a major step forward. Long-term daily use of acetylsalicylic acid (ASA) has been shown to reduce cancer risk in individuals with Lynch syndrome (LS). LS is caused by heterozygous germline variants of MSH2, MSH6, PMS2 and MLH1 and characterized by an increased risk of developing colorectal and endometrial cancer at adult age. Here we discuss the potential use of ASA for cancer prevention in patients with CMMRD.

摘要

错配修复缺陷综合征(CMMRD)是由同源或复合杂合的错配修复(MMR)基因(MSH2、MSH6、PMS2、MLH1)中的种系变异引起的。这种综合征会导致结直肠癌、白血病和淋巴瘤、脑肿瘤和其他恶性肿瘤的早发。CMMRD 患儿发生多种癌症的风险较高,癌症监测并不能保证在可治愈阶段检测到癌症。制定预防治疗策略将是向前迈出的重要一步。长期每天使用乙酰水杨酸(ASA)已被证明可以降低林奇综合征(LS)患者的癌症风险。LS 是由 MSH2、MSH6、PMS2 和 MLH1 的杂合种系变异引起的,其特征是成年后患结直肠癌和子宫内膜癌的风险增加。在这里,我们讨论了 ASA 用于预防 CMMRD 患者癌症的潜在用途。

相似文献

引用本文的文献

本文引用的文献

4
Aspirin and Cancer.阿司匹林与癌症。
J Am Coll Cardiol. 2016 Aug 30;68(9):967-76. doi: 10.1016/j.jacc.2016.05.083.
5
The role of aspirin in preventing colorectal cancer.阿司匹林在预防结直肠癌中的作用。
Br Med Bull. 2016 Sep;119(1):17-24. doi: 10.1093/bmb/ldw028. Epub 2016 Aug 19.
7
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.质子泵抑制剂的使用与慢性肾脏病风险
JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193.
8
Adverse Effects Associated With Proton Pump Inhibitors.质子泵抑制剂相关的不良反应。
JAMA Intern Med. 2016 Feb;176(2):172-4. doi: 10.1001/jamainternmed.2015.7927.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验